WellSpan Reciprocal RRG
Major Rating Factors:
Poor long-term capitalization index (1.0 on a scale of 0 to 10) based on weak current risk adjusted capital (severe and moderate loss scenarios), although results have slipped from the fair range during the last year. A history of deficient reserves (0.9) that places pressure on both capital and profits. In four of the last five years reserves (two year development) were between 34.2% and 123.0% deficient. Weak profitability index (2.7) with operating losses during 2020, 2021, 2023, 2024 and the first six months of 2025. Average return on equity over the last five years has been poor at -14.4%.
Other Rating Factors:
Weak overall results on stability tests (1.5) including weak risk adjusted capital in prior years. The largest net exposure for one risk is excessive at 17.5% of capital. Good liquidity (6.0) with sufficient resources (cash flows and marketable investments) to handle a spike in claims.
Stability Factors:
C - Past results on our Risk-Adjusted Capital tests.
D - Limited diversification of general business, policy, and/or investment risk.
T - Significant trends in critical asset, liability, income or expense items.
Principal Lines of Business:
Med mal (97.7%), other (2.3%)
Licensed in:
VT
Principal Investments:
Investment grade bonds (86.4%), other (13.6%)
Corporate Info
Group Affiliation
None
Investment Rating
--
Company Address
463 Mountain View
Colchester, VT 05446
Colchester, VT 05446
Phone Number
(802) 864-6118
NAIC Number
11682
Website
Largest Affiliates
No affiliate information available.